Tata India Pharma & Healthcare Fund - Growth - Direct Plan

  • Previous Nav

  • Net Change on 21-10-2021

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Tata India Pharma & Healthcare Fund-Direct Plan-Growth -3.02 -1.37 30.64 27.14 14.63 11.83
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
NIFTY PHARMA - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Dec 28, 2015 30.64 27.14 14.63 1.06 590.03
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 34.35 26.44 16.65 0.90 5,474.07
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 28.10 24.25 10.74 1.07 2,001.26
UTI Healthcare Fund - Direct Plan - Growth Option Jan 01, 2013 29.59 25.70 13.04 1.24 879.57

Fund Holdings as on 30-September-2021

  • SUN PHARMACEUTICAL INDUSTRIES LTD

  • DR REDDYs LABORATORIES LTD

  • DIVI LABORATORIES LTD

  • CIPLA LTD

  • ALKEM LABORATORIES LTD

  • IPCA LABORATORIES LTD

  • APOLLO HOSPITALS ENTERPRISE LTD

  • NARAYANA HRUDAYALAYA LTD

  • LUPIN LTD

  • FORTIS HEALTHCARE LTD

  • J.B.CHEMICALS & PHARMACEUTICALS LTD

  • KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD

  • PROCTER & GAMBLE HEALTH LTD

  • FDC LTD

  • INDOCO REMEDIES LTD

  • SYNGENE INTERNATIONAL LTD

  • METROPOLIS HEALTHCARE LTD

  • GLAND PHARMA LTD

  • ABBOTT INDIA LTD

  • HEALTHCARE GLOBAL ENTERPRISES LTD

  • AJANTA PHARMA LTD

  • GLENMARK PHARMACEUTICALS LTD

  • AUROBINDO PHARMA LTD

  • A) REPO

  • LAURUS LABS LTD

  • DR. LAL PATH LABS LTD

  • GLAXOSMITHKLINE PHARMACEUTICALS LTD

  • SANOFI INDIA LTD

  • KRSNAA DIAGNOSTICS LTD

  • SOLARA ACTIVE PHARMA SCIENCES LTD

  • NET CURRENT LIABILITIES

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About Tata India Pharma & Healthcare Fund

Scheme Analysis

Tata India Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Tata Mutual Fund. It was launched on 28-Dec-2015 and currently has an AUM of ₹590.03 crore. Tata India Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and NIFTY PHARMA - TRI as secondary index.

The NAV of Tata India Pharma & Healthcare Fund ended down ₹-0.06(-0.33%)yesterday to ₹19.1635.

Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD, and

The Tata India Pharma & Healthcare Fund is managed by Meeta Shetty .

Fund House Contact

1903, B Wing, Parinee Crescenzo, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051

+91 (22) 66578282
kiran@tataamc.com
+91 (22) 22613782